Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Curative Treatment”

497 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 497 results

Large-scale testing (Phase 3)Ended earlyNCT00014586
What this trial is testing

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 110
Not applicableNot Yet RecruitingNCT06777472
What this trial is testing

Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of Asthma

Who this might be right for
Asthma
Cuiling Feng 384
Large-scale testing (Phase 3)Study completedNCT04642469
What this trial is testing

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Who this might be right for
Carcinoma, Non- Small Cell Lung
AstraZeneca 30
Testing effectiveness (Phase 2)Looking for participantsNCT05771402
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 AntibodyPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00100945
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 70
Not applicableLooking for participantsNCT07058207
What this trial is testing

Weight Management in Obese Cancer Patients During Curative Active Treatment

Who this might be right for
ObesitySolid NeoplasmStage II-IV+1 more
Institut d'Investigació Biomèdica de Bellvitge 50
Post-approval studies (Phase 4)Study completedNCT03277339
What this trial is testing

Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders

Who this might be right for
Generalized Anxious Disorders
Centre Hospitalier Henri Laborit 52
Testing effectiveness (Phase 2)Looking for participantsNCT04966663
What this trial is testing

Using ctDNA to Determine Therapies for Lung Cancer

Who this might be right for
Non Small Cell Lung CancerComplete Surgical ResectionCirculating Tumor DNA
University Health Network, Toronto 66
Early research (Phase 1)Looking for participantsNCT03240328
What this trial is testing

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 40
Not applicableActive Not RecruitingNCT05087251
What this trial is testing

The Transitions Project: Efficacy Trial

Who this might be right for
Lung Cancer
Massachusetts General Hospital 100
Not applicableStudy completedNCT03424837
What this trial is testing

A Survivorship Care Plan and Embedded Navigation Tool

Who this might be right for
Prostate Cancer
Duke University 77
Not applicableActive Not RecruitingNCT07664267
What this trial is testing

Safety and Efficacy of MORA Cure LBP in Patients With Chronic Low Back Pain

Who this might be right for
Chronic Low Back Pain
EverEx Inc. 156
Not applicableStudy completedNCT02295579
What this trial is testing

Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida

Who this might be right for
Bacterial Vaginosis
Skaraborg Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00655161
What this trial is testing

A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation

Who this might be right for
NSCLC
GlobeImmune 24
Not applicableUnknownNCT05008796
What this trial is testing

PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT

Who this might be right for
Head and Neck Squamous Cell CarcinomaCirculating Tumor Cell
Chang Gung Memorial Hospital 50
Testing effectiveness (Phase 2)Study completedNCT05174806
What this trial is testing

Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients

Who this might be right for
Diabetic Foot InfectionDiabetic Foot
Microbion Corporation 47
Testing effectiveness (Phase 2)Looking for participantsNCT06092333
What this trial is testing

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Large-scale testing (Phase 3)Study completedNCT00104741
What this trial is testing

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 378
Testing effectiveness (Phase 2)UnknownNCT04632342
What this trial is testing

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Who this might be right for
Radiation PneumonitisLung Cancer
Hanlim Pharm. Co., Ltd. 87
Testing effectiveness (Phase 2)Study completedNCT07811882
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 95
Next Page